Amedisys Signs Definitive Agreement to Acquire Beacon Hospice

Amedisys, Inc. AMED today announced it has signed a definitive agreement to acquire Beacon Hospice, Inc. Beacon Hospice is headquartered in Boston, Mass.. Founded in 1993, Beacon has grown to include 23 free-standing locations and one inpatient unit, serving the states of Massachusetts, Maine, New Hampshire, Rhode Island and Connecticut . Total annualized revenue for Beacon in 2010 was approximately $80 million. This transaction remains subject to customary closing conditions, including regulatory approvals, and is expected to add $0.05 to $0.07 to Amedisys' earnings in 2011 excluding one-time transaction related costs. The parties have agreed in the definitive agreement to a purchase price of approximately $125 million, subject to customary adjustments.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsM&AHealth CareHealth Care Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!